Live News EQUITY FLASH L impact Oct 31, 2026, 07:20 AM UTC Zevra Therapeutics’ 12-Month Price Target Raised to $25.25 Valid market news retained in the public archive without immediate LiveCast distribution. ZVRA SquawkNews Desk